Healthcare Services

Ocular Genetic Diagnostic Market Forecast 2026–2035 Reflecting Expansion Opportunities Across Industries

April 3, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Expected For The Ocular Genetic Diagnostic Market At The End Of The 2026–2030 Forecast Period?

The market size for ocular genetic diagnostics has shown strong growth over recent years. This market is projected to expand from $1.07 billion in 2025 to $1.18 billion in 2026, at a compound annual growth rate (CAGR) of 9.5%. The historical growth can be ascribed to factors such as the increasing prevalence of inherited ocular conditions, advancements in sequencing technologies, the expansion of specialized ophthalmic clinics, heightened awareness of genetic eye disorders, and the enhanced capabilities of diagnostic laboratories.

The ocular genetic diagnostic market is projected to experience robust expansion over the next few years, with its size expected to reach $1.67 billion by 2030, growing at a compound annual growth rate (CAGR) of 9.3%. This anticipated growth is attributed to factors such as an escalating demand for personalized ophthalmic treatments, the increasing adoption of whole genome sequencing, the expansion of preventive genetic screening programs, the growing integration of AI in genetic interpretation, and rising investments in precision ophthalmology. Significant trends expected during this forecast period include a greater uptake of comprehensive genetic screening panels, the increasing utilization of next-generation sequencing in ophthalmology, enhanced early diagnosis for inherited eye disorders, the rising integration of genetic counseling services, and a heightened focus on precision eye care.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28283&type=smp

Which Market Drivers Are Supporting The Expansion Of The Ocular Genetic Diagnostic Market?

The expanding occurrence of eye conditions is anticipated to fuel the expansion of the ocular genetic diagnostic market in the future. Eye diseases encompass a range of health issues impacting the eye’s structure or how it functions, which can result in vision loss or blindness if not addressed. This increase in eye ailments is primarily attributed to greater screen exposure and usage of digital devices, causing symptoms like eye strain, dry eyes, and other vision problems. Ocular genetic diagnostics offers advantages for eye diseases by identifying inherited genetic elements early, providing enhanced understanding of disease origins, and assisting in more accurate diagnosis and treatment. For example, a survey conducted in February 2025 by the American Foundation for the Blind, a US-based organization dedicated to people with vision loss, revealed that 51.9 million American adults aged 18 and older reported experiencing some form of vision difficulty. Of these individuals, 3.7 million faced considerable difficulty seeing even with corrective lenses, while 307,000 were completely blind. The remaining 47.9 million indicated mild vision challenges despite using glasses. Consequently, the growing occurrence of eye diseases is propelling the market for ocular genetic diagnostics.

What Segment Types Make Up The Ocular Genetic Diagnostic Market?

The ocular genetic diagnostic market covered in this report is segmented –

1) By Test Type: Single Gene Testing, Panel Testing, Whole Exome Sequencing, Whole Genome Sequencing

2) By Technology Type: Sequencing Technology, Polymerase Chain Reaction (PCR), Microarray Technology, Next-Generation Sequencing (NGS)

3) By Application: Retinal Disorders, Cataract Diagnosis, Inherited Ocular Disorders, Age-Related Macular Degeneration

4) By End-User: Hospitals, Diagnostic Laboratories, Academic And Research Institutes, Other End-Users

Subsegments:

1) By Single Gene Testing: Retinoblastoma Gene Testing (RB1), RPE65 Gene Mutation Testing, MYOC Gene Testing (Glaucoma), OPA1 Gene Testing (Optic Atrophy), BEST1 Gene Testing (Best Disease)

2) By Panel Testing: Inherited Retinal Disease (IRD) Panels, Glaucoma Genetic Panels, Macular Dystrophy Panels, Optic Neuropathy Panels, Syndromic Ocular Disorder Panels

3) By Whole Exome Sequencing (WES): Trio Exome Sequencing, Diagnostic Exome Sequencing, Exome Reanalysis Services, Rapid Exome Testing, Prenatal Exome Sequencing

4) By Whole Genome Sequencing (WGS): Clinical Whole Genome Sequencing, Rapid Whole Genome Sequencing, Pediatric Genome Sequencing, Prenatal Whole Genome Sequencing, Ultra-Rare Eye Disease Genome Sequencing

What Trends Are Affecting The Expansion Of The Ocular Genetic Diagnostic Market?

Leading companies in the ocular genetic diagnostic market are concentrating on developing advanced offerings, such as clinical services, to improve early detection, diagnostic accuracy, and personalized treatment for inherited eye diseases. A clinical service is a healthcare activity delivered by professionals to evaluate, diagnose, treat, and manage patients’ health conditions. For instance, in October 2024, the Singapore National Eye Centre (SNEC), a Singapore-based public-sector specialty eye hospital, introduced the Ocular Genetics Service (OGS), a clinical service aimed at providing specialized care for individuals with hereditary eye conditions. This dedicated service centralizes genetic testing, counselling, and tailored clinical management, ensuring prompt diagnosis and intervention for rare genetic eye conditions. By integrating multidisciplinary expertise, the OGS enhances diagnostic precision and allows patients to access personalized care plans informed by their genetic profile. The launch of such clinical services indicates a broader shift in the ocular genetic diagnostics market towards precision medicine and comprehensive, patient-centered care models.

Who Are The Key Players Driving Competition In The Ocular Genetic Diagnostic Market?

Major companies operating in the ocular genetic diagnostic market are Thermo Fisher Scientific Inc., Quest Diagnostics Inc., Illumina Inc., The Children’s Hospital of Philadelphia, University of Iowa Hospitals and Clinics, PerkinElmer Inc., Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc., ARUP Laboratories Inc., Invitae Corporation, Spark Therapeutics Inc., GeneDx LLC, Blueprint Genetics Oy, Medgenome Labs Inc., Centogene NV, PreventionGenetics LLC, Molecular Vision Laboratory LLC, Casey Eye Institute, Moorfields Eye Hospital & UCL Institute of Ophthalmology.

Read the full ocular genetic diagnostic market report here:

https://www.thebusinessresearchcompany.com/report/ocular-genetic-diagnostic-global-market-report

How Is The Ocular Genetic Diagnostic Market Distributed Across Key Geographic Regions?

North America was the largest region in the ocular genetic diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ocular genetic diagnostic market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Ocular Genetic Diagnostic Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28283&type=smp

Browse Through More Reports Similar to the Global Ocular Genetic Diagnostic Market 2026, By The Business Research Company

Occupational Health Global Market Report

https://www.thebusinessresearchcompany.com/report/occupational-health-global-market-report

Occupational Medicines Global Market Report

https://www.thebusinessresearchcompany.com/report/occupational-medicines-global-market-report

Physical Therapy Global Market Report

https://www.thebusinessresearchcompany.com/report/physical-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795